The role of VWF in FVIII/VWF concentrates: biochemical characterization of three different plasma-derived factor VIII products

被引：0
|
作者：
Cristofaro, Raimondode [1 ]
Lancellotti, Stefano [1 ]
Filippis, Vincenzode [2 ]
Acquasaliente, Laura [2 ]
Valsecchi, Carla [3 ]
Garagiola, Sabella [3 ]
Peyvandi, Flora [3 ]
机构：
[1] Catholic Univ, Sch Med, Haemophilia & Thrombosis Ctr, Dpt Med Sci, Rome, Italy
[2] Univ Padua, Dpt Pharmaceut & Pharmacol Sci, Sch Med, I-35100 Padua, Italy
[3] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
来源：
HAEMOPHILIA | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [21] DEMONSTRATION AND CHARACTERIZATION OF FACTOR-VIII VON WILLEBRAND FACTOR (FVIII-VWF) RECEPTORS ON HUMAN PLATELETS
    KAO, KJ
    PIZZO, SV
    MCKEE, PA
    CIRCULATION, 1978, 58 (04) : 123 - 123
  • [22] CHARACTERIZATION OF PLASMA-DERIVED AND RECOMBINANT HUMAN VWF BY IMPROVED COLLAGEN-BINDING ASSAYS
    SIEKMANN, J
    TURECEK, PL
    FISCHER, BE
    MITTERER, A
    SCHLOKAT, U
    FALKNER, FG
    DORNER, F
    SCHWARZ, HP
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1160 - 1160
  • [23] Factor VIII safety: plasma-derived versus recombinant products
    Gringeri, Alessandro
    BLOOD TRANSFUSION, 2011, 9 (04) : 366 - 370
  • [24] Cellular Stress Induced by Plasma-Derived Factor VIII Products
    Brodde, Martin
    Mueller, Anja
    Kehrel, Beate
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2014, 41 (02) : 140 - 144
  • [25] The use of a VWF-containing plasma-derived FVIII product in inhibitor patients likely to fail immune tolerance induction
    Kurth, M. H.
    Puetz, J.
    Kouides, P.
    Sanders, J.
    Sexauer, C.
    Berstein, J.
    Gruppo, R.
    Manco-Johnson, M.
    Neufeld, E.
    Quon, D.
    Rodriguez, N.
    WIcklund, B.
    Aledort, L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 103 - 103
  • [26] Clinical Efficacy and Safety of Fanhdi(R), a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study
    Jimenez-Yuste, Victor
    Teresa Alvarez-Roman, Maria
    Palomo Bravo, Angeles
    Galmes, Bernardo J.
    Nieto Hernandez, Maria del Mar
    Benitez Hidalgo, Olga
    Marzo Alonso, Cristina
    Perez Gonzalez, Noelia Florencia
    Coll, Julia
    Nunez, Ramiro
    Carrasco, Marina
    Garcia Candel, Faustino
    Ramon Gonzalez-Porras, Jose
    Hernandez Garcia, Carmen
    Varo Castro, Maria Jose
    Mir, Roser
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [27] Clinical Efficacy and Safety of Fanhdi((R)), a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study
    Jimenez-Yuste, Victor
    Alvarez-Roman, Maria Teresa
    Palomo Bravo, Angeles
    Galmes, Bernardo J.
    Nieto Hernandez, Maria del Mar
    Benitez Hidalgo, Olga
    Marzo Alonso, Cristina
    Perez Gonzalez, Noelia Florencia
    Coll, Julia
    Nunez, Ramiro
    Carrasco, Marina
    Garcia Candel, Faustino
    Gonzalez-Porras, Jose Ramon
    Hernandez Garcia, Carmen
    Varo Castro, Maria Jose
    Mir, Roser
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [28] Clinical Efficacy and Safety of Fanhdi (R), a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study
    Jimenez-Yuste, Victor
    Alvarez-Roman, Maria Teresa
    Bravo, Angeles Palomo
    Galmes, Bernardo J.
    Hernandez, Maria del Mar Nieto
    Hidalgo, Olga Benitez
    Alonso, Cristina Marzo
    Gonzalez, Noelia Florencia Perez
    Coll, Julia
    Nunez, Ramiro
    Carrasco, Marina
    Candel, Faustino Garcia
    Gonzalez-Porras, Jose Ramon
    Garcia, Carmen Hernandez
    Castro, Maria Jose Varo
    Mir, Roser
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [29] TREATMENT WITH A PLASMA-DERIVED VON WILLEBRAND FACTOR (VWF) ALMOST DEVOID OF FACTOR VIII IN ELDERLY PATIENTS WITH VON WILLEBRAND DISEASE (VWD): A POOLED ANALYSIS
    Goudemand, J.
    Derlon, A. Borel
    Henriet, C.
    Susen, S.
    Repesse, Y.
    HAEMOPHILIA, 2022, 28 : 109 - 110
  • [30] TREATMENT WITH A PLASMA-DERIVED VON WILLEBRAND FACTOR (VWF) ALMOST DEVOID OF FACTOR VIII IN PAEDIATRIC PATIENTS WITH VON WILLEBRAND DISEASE (VWD): A POOLED ANALYSIS
    Goudemand, J.
    Borel-Derlon, A.
    Henriet, C.
    Repesse, Y.
    Susen, S.
    HAEMOPHILIA, 2023, 29 : 147 - 147
12345